These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32194244)

  • 1. Repeated but not acute exposure with a low dose range of the nitric oxide (NO) donor sodium nitroprusside (SNP) induces anxiolytic-like behaviour in a dose-independent manner in two different rat models of anxiety.
    Papageorgoulis A; Fallon P; Mpalantes N; Papageorgouli D; Pitsikas N
    Nitric Oxide; 2020 Jun; 99():1-6. PubMed ID: 32194244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and repeated exposure with the nitric oxide (NO) donor sodium nitroprusside (SNP) differentially modulate responses in a rat model of anxiety.
    Orfanidou MA; Lafioniatis A; Trevlopoulou A; Touzlatzi N; Pitsikas N
    Nitric Oxide; 2017 Sep; 69():56-60. PubMed ID: 28522342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety.
    Kalouda T; Pitsikas N
    Pharmacol Biochem Behav; 2015 Nov; 138():111-6. PubMed ID: 26363313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.
    Trevlopoulou A; Touzlatzi N; Pitsikas N
    Psychopharmacology (Berl); 2016 Mar; 233(6):1045-54. PubMed ID: 26685991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sodium nitroprusside in the acute dizocilpine (MK-801) animal model of schizophrenia.
    Wang X; Ding S; Lu Y; Jiao Z; Zhang L; Zhang Y; Yang Y; Zhang Y; Li W; Lv L
    Brain Res Bull; 2019 Apr; 147():140-147. PubMed ID: 30772438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.
    Diana MC; Peres FF; Justi V; Bressan RA; Lacerda ALT; Crippa JA; Hallak JEC; Abilio VC
    CNS Neurosci Ther; 2018 Jul; 24(7):624-632. PubMed ID: 29656549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety.
    Grivas V; Markou A; Pitsikas N
    Eur J Pharmacol; 2013 Sep; 715(1-3):105-10. PubMed ID: 23769742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of systemically administered nitric oxide donor, sodium nitroprusside on picrotoxin-induced convulsions in rats.
    Rajasekaran K; Reddy PL; Paul V
    Indian J Physiol Pharmacol; 2001 Jan; 45(1):95-100. PubMed ID: 11211577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low doses of different nitric oxide (NO) donors in rat models of obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD).
    Peristeri E; Pitsikas N
    Nitric Oxide; 2022 Dec; 129():1-7. PubMed ID: 36084795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice.
    Pultrini Ade M; Galindo LA; Costa M
    Life Sci; 2006 Mar; 78(15):1720-5. PubMed ID: 16253279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ventral hippocampal nitric oxide/cGMP pathway in anxiety-related behaviors in rats submitted to the elevated T-maze.
    Calixto AV; Duarte FS; Duzzioni M; Nascimento Häckl LP; Faria MS; De Lima TC
    Behav Brain Res; 2010 Feb; 207(1):112-7. PubMed ID: 19800925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic activity of aqueous extract of
    Shastry R; Ullal SD; Karkala S; Rai S; Gadgade A
    Indian J Pharmacol; 2016; 48(6):681-686. PubMed ID: 28066107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    Indian J Exp Biol; 2013 Jul; 51(7):510-4. PubMed ID: 23898549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week.
    Maia-de-Oliveira JP; Lobão-Soares B; Ramalho T; Gavioli EC; Soares VP; Teixeira L; Baker GB; Dursun SM; Hallak JE
    Schizophr Res; 2015 Mar; 162(1-3):211-5. PubMed ID: 25586741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO-sGC-cGMP signaling influence the anxiolytic like effect of lithium in mice in light and dark box and elevated plus maze.
    Walia V; Garg C; Garg M
    Brain Res; 2019 Feb; 1704():114-126. PubMed ID: 30292770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
    Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
    Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium nitroprusside impairs sexual competence of male rats.
    Ratnasooriya WD; Jayakody JR; Dharmasiri MG
    Hum Exp Toxicol; 2004 Apr; 23(4):187-92. PubMed ID: 15171569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic-like effects of inhaled linalool oxide in experimental mouse anxiety models.
    Souto-Maior FN; de Carvalho FL; de Morais LC; Netto SM; de Sousa DP; de Almeida RN
    Pharmacol Biochem Behav; 2011 Dec; 100(2):259-63. PubMed ID: 21925533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests.
    Chaouloff F; Durand M; Mormède P
    Behav Brain Res; 1997 Apr; 85(1):27-35. PubMed ID: 9095339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low doses of the novel dehydroepiandrosterone (DHEA) derivative BNN27 in rat models of anxiety.
    Fragkiadaki E; Katsanou L; Vartzoka F; Gravanis A; Pitsikas N
    Psychopharmacology (Berl); 2024 Feb; 241(2):341-350. PubMed ID: 37917180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.